[go: up one dir, main page]

AU2407400A - Process for the formation of intermediates useful for the preparation of pharmaceuticals - Google Patents

Process for the formation of intermediates useful for the preparation of pharmaceuticals

Info

Publication number
AU2407400A
AU2407400A AU24074/00A AU2407400A AU2407400A AU 2407400 A AU2407400 A AU 2407400A AU 24074/00 A AU24074/00 A AU 24074/00A AU 2407400 A AU2407400 A AU 2407400A AU 2407400 A AU2407400 A AU 2407400A
Authority
AU
Australia
Prior art keywords
pharmaceuticals
formation
preparation
intermediates useful
intermediates
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU24074/00A
Inventor
Patricia Ann Oliver
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Vertex Pharmaceuticals Inc
Original Assignee
Vertex Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vertex Pharmaceuticals Inc filed Critical Vertex Pharmaceuticals Inc
Publication of AU2407400A publication Critical patent/AU2407400A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D203/00—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D203/04—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D203/06—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D203/08—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/30—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36—Radicals substituted by singly-bound nitrogen atoms
    • C07D213/38—Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/08—Compounds containing oxirane rings with hydrocarbon radicals, substituted by halogen atoms, nitro radicals or nitroso radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
AU24074/00A 1999-01-08 2000-01-07 Process for the formation of intermediates useful for the preparation of pharmaceuticals Abandoned AU2407400A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US11525699P 1999-01-08 1999-01-08
US60115256 1999-01-08
PCT/US2000/000313 WO2000040557A1 (en) 1999-01-08 2000-01-07 Process for the formation of intermediates useful for the preparation of pharmaceuticals

Publications (1)

Publication Number Publication Date
AU2407400A true AU2407400A (en) 2000-07-24

Family

ID=22360210

Family Applications (1)

Application Number Title Priority Date Filing Date
AU24074/00A Abandoned AU2407400A (en) 1999-01-08 2000-01-07 Process for the formation of intermediates useful for the preparation of pharmaceuticals

Country Status (4)

Country Link
EP (1) EP1140844A1 (en)
JP (1) JP2002534414A (en)
AU (1) AU2407400A (en)
WO (1) WO2000040557A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109020813A (en) * 2017-06-12 2018-12-18 北京大学 A kind of new method preparing alpha-brominated -3,4- dimethoxyphenylacetic acid ethapon ester

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL115685A (en) * 1994-11-16 2000-08-31 Vertex Pharma Amino acid derivatives pharmaceutical compositions containing the same and processes for the preparation thereof
US5977105A (en) * 1995-12-06 1999-11-02 Astra Pharmaeuticals Ltd. Compounds
US5840736A (en) * 1996-11-13 1998-11-24 Vertex Pharmaceuticals Incorporated Methods and compositions for stimulating neurite growth
TR199902433T2 (en) * 1997-04-01 2000-04-21 Astra Pharmaceuticals Ltd. New pyridine derivatives and pharmaceutical compositions containing them.

Also Published As

Publication number Publication date
EP1140844A1 (en) 2001-10-10
JP2002534414A (en) 2002-10-15
WO2000040557A1 (en) 2000-07-13

Similar Documents

Publication Publication Date Title
AU7902400A (en) Method for the preparation of 5-carboxyphthalide
AU5558800A (en) Process for the production of 2-(2-pyridinylmethylsulphinyl)-1h-benzimidazoles
AU6432800A (en) Process for the synthesis of citalopram
HK1045309A1 (en) Preparation of substituted piperidin-4-ones
AU2466700A (en) Process for the preparation of urea
AU7972200A (en) Process for the preparation of urea
AU7321900A (en) Process for the production of aspartyldipeptide ester derivatives, novel intermediates therefor and process for the production of the intermediates
AU2682200A (en) Process for the production of olefins
AU1434301A (en) Process for the preparation of sulfamides
AU1651001A (en) Difluoromethyltriazolone compounds, use of the same and intermediates for the production thereof
AU7918200A (en) Oxidation process for the preparation of intermediates useful in the synthesis of diarylpyridines
AU1037901A (en) Process for the preparation of paroxetine
AU2943400A (en) Process for the preparation of alpha-aminoketone derivatives
AU7958000A (en) Process for the preparation of oxyiminoalkanoic acid derivatives
AU4151700A (en) Process for the preparation of caprolactam
AU2829700A (en) Processes for the preparation of alpha-aminoketones
AU6870600A (en) Process for the preparation of 2,3-dihydroazepine compounds
AU5415900A (en) Process for the preparation of butoxycarbonylimino compounds and intermediates therefor
AU2672301A (en) Process for the biotechnological preparation of l-erythrulose
AU2643599A (en) Process for the preparation of epsilon-caprolactam
AU2155501A (en) Process for the preparation of ketimines
AU1130901A (en) Method for the preparation of 5-carboxyphthalide
AU2407400A (en) Process for the formation of intermediates useful for the preparation of pharmaceuticals
AU7224300A (en) Process for the preparation of cefpodoxime acid
AU5109600A (en) Process for the production of 2-pyridylpyridine derivatives

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase